Bas van Buijtenen

Bas van Buijtenen has extensive work experience in various leadership roles. Bas has served as the President Injectables Division at AptarGroup, Inc. and held global and regional leadership roles in Human Nutrition and Health at DSM Nutritional Products. Bas also served as a Board Member at BIOMILLENIA, an Independent Board Member at Microphyt, and a Board Member at ABC transfer. Bas was the Chief Executive Officer at LTS Lohmann Therapie-Systeme AG. Bas has also held multiple roles at DSM, including Business Unit President, VP Executive Sourcing, and Business Leadership roles in Engineering Plastics and Polyethylenes. Bas has a strong background in sales, business development, and management. Currently, they are an Independent Supervisory Board Member at SGD Pharma.

Bas van Buijtenen has an extensive education history. Bas obtained a Master's degree in Business Studies from the University of Groningen, attending from 1984 to 1989. Prior to that, they attended the Europese School from 1979 to 1984, though no specific degree or field of study is mentioned.

Furthermore, Bas van Buijtenen pursued several executive programs to enhance their knowledge and skills in the business field. In 1998 and 1999, they completed the Building On Talent program at IMD. In 2005, they participated in the Advanced Management Programme (AMP) at INSEAD. Additionally, in 2019 and 2020, they completed the International Directors Program at INSEAD.

Recent education endeavors include obtaining a Certificate in Corporate Governance from INSEAD Executive Education in April 2021. In February 2022, Bas van Buijtenen attended the Harvard Business School, completing the Finance for Senior Executives program, specifically focusing on Accounting and Finance.

Based on the given information, it is also evident that Bas van Buijtenen has gained additional certifications related to their career. This includes obtaining the Finance for Senior Executives certification from Harvard Business School in February 2022, and the Certificate in Corporate Governance from INSEAD Executive Education in April 2021.